Oxehealth & Oxford Health Win Building Better Healthcare's Best Healthcare Software Product" Award"
The 21st annual “Building Better Healthcare Awards” ceremony was held at The Brewery in London on October 30th, 2019. The awards are recognised nationally, attracting directors, architects, designers and senior buyer level delegates from across the NHS,
Awards were presented in 22 categories across four different classes, covering Building Design, Patient Environment, Technology, and Estates and Facilities Management, plus there were three special awards, Patient’s Choice, Clinician’s Choice, and the Grand Prix Design Award, which was presented to the best healthcare development of the year.
With our wonderful partners at Oxford Health, we took home the award for "Best Healthcare Software product", in which we submitted our latest clinical-based outcome report: A good nights sleep in mental health hospitals (Oxford Health NHS Foundation Trust and Oxehealth), where results showed improved wellbeing and quicker recovery is now possible for mental health patients.
Oxford Health NHS Foundation Trust developed a new observation protocol that enables nurses on the ward to use the DCA alongside their clinical judgment to avoid disrupting patients’ sleep.
The trust installed the DCA in six higher acuity bedrooms on Vaughan Thomas, a male inpatient ward at Warneford Hospital, where nurses would normally check on patients in person every 15/30 minutes during the night.
Using an optical sensor, the software detects and alerts staff to patient movement and can measure their vital signs with medical grade accuracy (Class IIa medical device; spot check pulse & breathing rate observations; world first software). As there is no device attached to the patient, the system allows for regular checks without disruption. It works even in total darkness.
“Nurses have seen this as a way to improve their relationship with patients and their experience of the ward. The project has also shown staff that problems can be solved. We can be innovative and use technology to deliver real benefits for patients.” An evaluation of the new approach at Oxford Health found the observation protocol allowed nurses to check on patients at night without waking them up or disturbing their rest. Between February and April this year, more than 5,000 observations were undertaken over 300 patient-nights using the new protocol. An in-depth evaluation of a 52-observation sample over six nights confirmed observations done with the help of the Digital Care Assistant were just as safe as those done without it.
About Oxehealth
Oxehealth was founded by the head of engineering at Oxford University, Professor Lionel Tarassenko in 2012. Since then, it has become a UK tech success story, with financial backing from IP Group Plc and Ora Capital, two major investment trusts committed to supporting UK science for the long-term. Oxehealth’s Digital Care Assistant products are already used by nine mental health trusts (17% of all the mental health trusts in England), three care home chains in the UK and Sweden and two police forces.
Oxehealth’s software solutions act as an assistant for staff when they cannot be present in a room, or do not want to disturb an individual. They enable optical sensors to alert clinicians, carers and custodians to high-risk activity, take spot vital sign measurements and review activity reports. This helps staff to improve the care of the elderly and vulnerable by reducing injuries and enabling staff to spend more time on hands-on care.
A case study has been published about Oxehealth’s work at Manor Hospital, part of Coventry and Warwickshire Partnership NHS Foundation Trust, where falls are a major risk. Staff report that the Digital Care Assistant has “become the sixth member of our team on the night shift.”
About Oxehealth’s vital signs measurement software
Oxehealth uses proprietary signal processing and computer vision to process normal digital video camera data to measure pulse rate and breathing rate and is intended for the non-invasive spot measurement of these vital signs.
It is a fixed-installation device for use within single occupancy rooms covered by a framework that mandates periodic checks by a trained professional to ensure subject safety. See device Instructions for Use for intended use, contraindications, warnings, cautions, usage directions and maintenance.
For further information visit:
https://twitter.com/Oxehealth
https://www.linkedin.com/company/Oxehealth/
For Media enquiries contact:
Susan Venables,
Highland Marketing on behalf of Oxehealth
+44 (0)1877 339922
+44 (0)7971 166936
